Considering that the neuroprotective role of the BDNF pathway has been reported in previous studies and combining evidence from other depression studies, we hypothesized that the inhibition of autophagy in microglia may have a detrimental effect on fluoxetine treatment for PPD through upregulation of inflammation and reduced BDNF expression. Here, BDNF is linked to depressive disorder.